Articles tagged with: Pfizer
How do we solve the rare disease crisis? In Conversation With…
27 May Tech & Research
How do we solve the rare disease crisis?
Pfizer often made the headlines over the past year after mobilising their scientific expertise and manufacturing capabilities to respond to the COVID-19 pandemic. Reda Guiha, Regional President for Rare Disease at Pfizer, argues that the same sense of urgency and public-private sector collaboration that brought vaccines to patients within a year should be applied to other areas of critical unmet medical need, such as rare disease.